Who are Xeris Biopharma Holdings, Inc.'s main suppliers?

Xeris Biopharma Holdings, Inc. (XERS) key suppliers include: Corcept Therapeutics Incorporated, Corcept Therapeutics Incorporated, ORANY, ORANY, Teva Pharmaceutical Industries Limited and 2 more. View the full supplier network at chainsifter.com/chain/XERS.

Who are Xeris Biopharma Holdings, Inc.'s major customers?

Xeris Biopharma Holdings, Inc. (XERS) key customers include: Corcept Therapeutics Incorporated, Corcept Therapeutics Incorporated, ORANY, ORANY, Teva Pharmaceutical Industries Limited and 2 more. View the full customer network at chainsifter.com/chain/XERS.

What sector is Xeris Biopharma Holdings, Inc. in?

Xeris Biopharma Holdings, Inc. (XERS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Xeris Biopharma Holdings, Inc. Suppliers, Customers & Supply Chain (XERS)

7Suppliers

7Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Xeris Biopharma Holdings, Inc. (XERS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships

3Distinct source URLs

4High confidence

0.749Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Xeris Biopharma Holdings, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CORT	Corcept Therapeutics Incorporated	72%	Reciprocal relationship from CORT graph: range of disorders, including central serous retinopathy, post-traumatic stress disorder, anxiety, alcoholism, cocaine addiction, Alzheimer’s disease, ALS, hy…
CORT	Corcept Therapeutics Incorporated	72%	duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan…
ORANY	ORANY	72%	completion of extensive preclinical laboratory tests, animal studies and formulation studies in accordance with applicable regulations, including the FDA’s Good Laboratory Practice ("GLP") regulation…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: completion of extensive preclinical laboratory tests, animal studies and formulation studies in accordance with appl…
TEVJF	Teva Pharmaceutical Industries Limited	72%	duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan…
TEVJF	Teva Pharmaceutical Industries Limited	72%	Reciprocal relationship from TEVJF graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC…
BBNX	Beta Bionics, Inc.	62%	Reciprocal relationship from BBNX graph: ile application delivers real-time glucose readings, trends and graphs, with data securely stored in the cloud. To maximize the commercial value of the iLet o…

Xeris Biopharma Holdings, Inc. Customers

Ticker	Name	Confidence	Evidence
CORT	Corcept Therapeutics Incorporated	72%	duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan…
CORT	Corcept Therapeutics Incorporated	72%	Reciprocal relationship from CORT graph: Reciprocal relationship from XERS graph: Reciprocal relationship from CORT graph: ol synthesis inhibitor osilodrostat to treat patients with Cushing’s disease…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a propri…
ORANY	ORANY	72%	duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan…
TEVJF	Teva Pharmaceutical Industries Limited	72%	duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC (collectively "SHL"). SHL produces device sub-assemblies at its facility in Taiwan…
TEVJF	Teva Pharmaceutical Industries Limited	72%	Reciprocal relationship from TEVJF graph: Reciprocal relationship from XERS graph: duct in Gvoke HypoPen is a proprietary multi-product device platform developed by SHL Medical AG and SHL Pharma, LLC…
TARO-PHARMACEUTICALS-NORTH-AMERICA-INC	TARO-PHARMACEUTICALS-NORTH-AMERICA-INC	62%	vements are limited by the expected lease term, which includes renewal options reasonably certain to be exercised. The majority of the Company's real estate leases require that the Company pay mainte…

Xeris Biopharma Holdings, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
XERS-DEBT	Debt stack $252.6M	90%	Market cache reports total debt of $252.6M.
XERS-DEBT-13655	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2025-12-31.
XERS-DEBT-13654	Warrants outstanding: 2275313	90%	xbrl warrant detail from xbrl 2026-01-31.

Xeris Biopharma Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Xeris Biopharma Holdings, Inc..

Xeris Biopharma Holdings, Inc. Ownership

Holder	Name	Confidence	Evidence
XERS-OWNER-BLACKROCK-INC	BlackRock, Inc.	90%	13F overlay lists BlackRock, Inc. as top holder; 240 tracked holders.

Xeris Biopharma Holdings, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
TEVJF	Teva Pharmaceutical Industries Limited	100.00	1	['customer', 'supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
BBNX	Beta Bionics, Inc.	100.00	1	['supplier']
CORT	Corcept Therapeutics Incorporated	100.00	1	['customer', 'supplier']
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
D	Dominion Energy, Inc.	50.00	2

Xeris Biopharma Holdings, Inc. Supply Chain